COLL
Collegium Pharmaceutical, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +3 | 27.25M | $986.22M | +8 | −5 |
| Q1 2026 | 98 | -1 | 28.14M | $930.88M | +7 | −9 |
| Q4 2025 | 100 | 0 | 26.92M | $1.25B | +1 | — |
| Q3 2025 | 19 | +2 | 14.79M | $517.39M | +2 | — |
| Q2 2025 | 14 | +1 | 12.36M | $365.37M | +1 | — |
| Q1 2025 | 10 | -1 | 5.48M | $163.49M | — | −1 |
| Q4 2024 | 11 | -1 | 5.00M | $143.28M | — | −1 |
| Q3 2024 | 11 | -1 | 3.77M | $145.78M | — | −1 |
| Q2 2024 | 12 | — | 3.67M | $118.10M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.53M | — | $49.31M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 770.12K | — | $24.80M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 770.12K | — | $24.80M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 303.87K | — | $9.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 254.77K | — | $8.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 198.86K | — | $6.40M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 172.67K | — | $5.56M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 172.67K | — | $5.56M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 101.96K | — | $3.28M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 101.96K | — | $3.28M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 97.86K | — | $3.15M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 97.86K | — | $3.15M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 72.74K | — | $2.34M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 70.96K | — | $2.29M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 70.96K | — | $2.29M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 61.42K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 30.86K | — | $994,000 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 5.10M acciones, $5.91M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.